Reductive stress in cancer immunology and targeted therapy.
Reductive stress is characterized by the excessive accumulation of cellular reducing equivalents, leading to the disruption of cellular redox homeostasis and a shift toward a reductive intracellular e
APA
Ji X, Xiao G (2026). Reductive stress in cancer immunology and targeted therapy.. Acta biochimica et biophysica Sinica, 58(1), 25-38. https://doi.org/10.3724/abbs.2025173
MLA
Ji X, et al.. "Reductive stress in cancer immunology and targeted therapy.." Acta biochimica et biophysica Sinica, vol. 58, no. 1, 2026, pp. 25-38.
PMID
40975792
Abstract
Reductive stress is characterized by the excessive accumulation of cellular reducing equivalents, leading to the disruption of cellular redox homeostasis and a shift toward a reductive intracellular environment. Immune cells exhibit particularly dynamic redox modulation to adapt to activation and differentiation processes during immune responses, such as tumor recognition and destruction. Unlike their immune counterparts, tumor cells employ a specific metabolic mode for uncontrolled proliferation and survival, which may also lead to a shift in the intracellular redox balance. While extensive research has focused on oxidative stress during the immune response and cancer treatment, studies on reductive stress are still in their infancy. This review summarizes the generation process of reductive stress and its impact on cellular function, detailing its mechanisms in immune cells and various cancers, as well as its relevance to cancer treatment. The aim of this study is to explore new avenues for cancer immunotherapy from the perspective of reductive stress.
MeSH Terms
Humans; Neoplasms; Immunotherapy; Oxidation-Reduction; Oxidative Stress; Animals; Molecular Targeted Therapy
같은 제1저자의 인용 많은 논문 (5)
- Mechanism of cancer-associated fibroblast-driven thyroid cancer dedifferentiation via the ZFP57-PKM2 axis-mediated lactate secretion and therapeutic intervention with resveratrol.
- Functional role of deubiquitinating enzyme USP39 in inhibiting pyroptosis in human acute myeloid leukemia.
- Replacing BPA: Structural Substitutes BPAF Binding to the Progesterone Receptor Elevates Breast Cancer Risk.
- Hepatic carcinosarcoma with predominant sarcomatous component mimicking intrahepatic cholangiocarcinoma: a case report and literature review.
- Pedicled versus free flap reconstruction in head and neck surgery: analysis of complications and quality of life.